A detailed history of Schwartz Investment Counsel Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Schwartz Investment Counsel Inc holds 2,463 shares of JNJ stock, worth $357,800. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,463
Previous 2,463 -0.0%
Holding current value
$357,800
Previous $359,000 11.14%
% of portfolio
0.02%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023

SELL
$155.75 - $174.48 $93,450 - $104,688
-600 Reduced 19.59%
2,463 $383,000
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $15,435 - $16,611
-100 Reduced 3.16%
3,063 $506,000
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $15,105 - $18,026
-100 Reduced 3.06%
3,163 $490,000
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $14,035 - $15,618
-87 Reduced 2.6%
3,263 $533,000
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $62,939 - $71,476
-398 Reduced 10.62%
3,350 $594,000
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $22,960 - $25,572
-150 Reduced 3.85%
3,748 $616,000
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $27,422 - $31,476
-200 Reduced 4.88%
3,898 $613,000
Q3 2020

Nov 17, 2020

SELL
$140.38 - $153.83 $14,038 - $15,383
-100 Reduced 2.38%
4,098 $610,000
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $51,781 - $62,515
-402 Reduced 8.74%
4,198 $590,000
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $33,342 - $46,197
-300 Reduced 6.12%
4,600 $603,000
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $63,475 - $71,070
-500 Reduced 9.26%
4,900 $634,000
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $88.6 Million - $97.7 Million
-741,754 Reduced 99.28%
5,400 $655,000
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $92.8 Million - $110 Million
741,754 Added 13736.19%
747,154 $26.8 Million
Q3 2017

Oct 27, 2017

BUY
$129.47 - $135.38 $699,138 - $731,052
5,400
5,400 $702,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Schwartz Investment Counsel Inc Portfolio

Follow Schwartz Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwartz Investment Counsel Inc with notifications on news.